Effects of curcumin in an orthotopic murine bladder tumor model

International Braz J Urol

Volumn 35, Issue 5, 2009, Pages 599-606

  Leite, Katia R M ^a,b   Chade, Daher C ^a,b   Sanudo, Adriana ^a,b   Sakiyama, Bruno Y P ^a,b   Batocchio, Gustavo ^a,b   Srougi, Miguel ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Genoa Biotechnology   (Brazil)

Author keywords

Bladder neoplasms; Cox 2; Curcumin; Cyclin D1; Drug therapy; NF B

Indexed keywords

ANTINEOPLASTIC AGENT; BCL2 PROTEIN, MOUSE; CURCUMIN; CYCLIN D1; CYCLOOXYGENASE 2; ONCOPROTEIN; PTGS2 PROTEIN, MOUSE;

ANIMAL; ARTICLE; BLADDER TUMOR; C57BL MOUSE; DISEASE MODEL; DRUG SCREENING; FEMALE; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUSE; PATHOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; CURCUMIN; CYCLIN D1; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; PROTO-ONCOGENE PROTEINS; URINARY BLADDER NEOPLASMS;

EID: 77949550447     PISSN: 16775538     EISSN: 16776119     Source Type: Journal    
DOI: 10.1590/S1677-55382009000500012     Document Type: Article

References (15)

1. Malkowicz SB: Management of Superficial Bladder Cancer. In: Walsh PC, Retik AB Vaughan Jr ED, et al. (eds.), Campbell's Urology. WB Saunders, Philadelphia. 2002; 8th ed., pp. 2785-802.
2. Hoffmann D, Hoffmann I, El-Bayoumy K: The less harmful cigarette: a controversial issue. a tribute to Ernst L. Wynder. Chem Res Toxicol. 2001; 14: 767-90.
3. Kim DW, Sovak MA, Zanieski G, Nonet G, Romieu-Mourez R, Lau AW, et al: Activation of NF-kappaB/Rel occurs early during neoplastic transformation of mammary cells. Carcinogenesis. 2000; 21: 871-9.
4. Garg A, Aggarwal BB: Nuclear transcription factor-kappaB as a target for cancer drug development. Leukemia. 2002; 16: 1053-68.
5. Herr HW, Wartinger DD, Fair WR, Oettgen HF: Bacillus Calmette-Guerin therapy for superficial bladder cancer: a 10-year followup. J Urol. 1992; 147: 1020-3.
6. Aggarwal BB, Harikumar KB: Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol. 2009; 41: 40-59.
7. Piantino CB, Salvadori FA, Ayres PP, Kato RB, Srougi V, Leite KR, Srougi M. An evaluation of the anti-neoplastic activity of curcumin in prostate cancer cell lines. Int Braz J Urol. 2009; 35: 354-60.
8. Aggarwal S, Ichikawa H, Takada Y, Sandur SK, Shishodia S, Aggarwal BB: Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. Mol Pharmacol. 2006; 69: 195-206.
9. Günther JH, Jurczok A, Wulf T, Brandau S, Deinert I, Jocham D, et al: Optimizing syngeneic orthotopic murine bladder cancer (MB49). Cancer Res. 1999; 59: 2834-7.
10. Chade DC, Andrade PM, Borra RC, Leite KR, Andrade E, Villanova FE, et al: Histopathological characterization of a syngeneic orthotopic murine bladder cancer model. Int Braz J Urol. 2008; 34: 220-6; discussion 226-9.
11. Fodor I, Timiryasova T, Denes B, Yoshida J, Ruckle H, Lilly M: Vaccinia virus mediated p53 gene therapy for bladder cancer in an orthotopic murine model. J Urol. 2005; 173: 604-9.
12. Kamat AM, Sethi G, Aggarwal BB: Curcumin potentiates the apoptotic effects of chemotherapeutic agents and cytokines through down-regulation of nuclear factor-kappaB and nuclear factor-kappaB-regulated gene products in IFN-alpha-sensitive and IFN-alpha-resistant human bladder cancer cells. Mol Cancer Ther. 2007; 6: 1022-30.
13. Hall MC, Chang SS, Dalbagni G, Pruthi RS, Seigne JD, Skinner EC, et al: Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. J Urol. 2007; 178: 2314-30.
14. Park C, Kim GY, Kim GD, Choi BT, Park YM, Choi YH: Induction of G2/M arrest and inhibition of cyclooxygenase-2 activity by curcumin in human bladder cancer T24 cells. Oncol Rep. 2006; 15: 1225-31.
15. Chadalapaka G, Jutooru I, Chintharlapalli S, Papineni S, Smith R 3rd, Li X, et al: Curcumin decreases specificity protein expression in bladder cancer cells. Cancer Res. 2008; 68: 5345-54.